Detalhe da pesquisa
1.
Clinicopathological features and resistance mechanisms in HIP1-ALK-rearranged lung cancer: A multicenter study.
Genes Chromosomes Cancer
; 61(4): 177-186, 2022 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-34687488
2.
Ginsenoside compound K inhibits growth of lung cancer cells via HIF-1α-mediated glucose metabolism.
Cell Mol Biol (Noisy-le-grand)
; 65(4): 48-52, 2019 Apr 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-31078152
3.
Association between BIM polymorphism and lung cancer outcomes: a meta-analysis.
Cell Mol Biol (Noisy-le-grand)
; 64(11): 92-96, 2018 Aug 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-30213299
4.
A meta-analysis of association between serum iron levels and lung cancer risk.
Cell Mol Biol (Noisy-le-grand)
; 64(13): 33-37, 2018 Oct 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-30403607
5.
Combined detection of CEA and CA125 for the diagnosis for lung cancer: A meta-analysis.
Cell Mol Biol (Noisy-le-grand)
; 64(15): 67-70, 2018 Dec 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-30672447
6.
Induction immune-checkpoint inhibitors for resectable oncogene-mutant NSCLC: A multicenter pooled analysis.
NPJ Precis Oncol
; 6(1): 66, 2022 Sep 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-36123526
7.
Hepatoid adenocarcinoma of the lung: An analysis of the Surveillance, Epidemiology, and End Results (SEER) database.
Open Med (Wars)
; 16(1): 169-174, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-33585692
8.
Eye metastasis in lung adenocarcinoma mimicking anterior scleritis: A case report.
World J Clin Cases
; 8(2): 410-414, 2020 Jan 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-32047793
9.
A prostate cancer patient with isolated lung metastases: a case report.
Transl Cancer Res
; 9(3): 2064-2068, 2020 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-35117556
10.
A Novel Oncogenic Driver in a Lung Adenocarcinoma Patient Harboring an EGFR-KDD and Response to Afatinib.
Front Oncol
; 10: 867, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32656077
11.
PD-L1 expression level in different thymoma stages and thymic carcinoma: a meta-analysis.
Tumori
; 106(4): 306-311, 2020 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-32366210
12.
A novel SOS1-ALK fusion variant in a patient with metastatic lung adenocarcinoma and a remarkable response to crizotinib.
Lung Cancer
; 142: 59-62, 2020 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-32114282
13.
A Real-World Study in Advanced Non-Small Cell Lung Cancer with KRAS Mutations.
Transl Oncol
; 13(2): 329-335, 2020 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-31881505
14.
Clinicopathological features and clinical efficacy of crizotinib in Chinese patients with ROS1-positive non-small cell lung cancer.
Oncol Lett
; 17(3): 3466-3474, 2019 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-30867785
15.
Effect of icotinib on advanced lung adenocarcinoma patients with sensitive EGFR mutation detected in ctDNA by ddPCR.
Transl Cancer Res
; 8(8): 2858-2863, 2019 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-35117043
16.
Intestinal metastasis from primary ROS1-positive lung adenocarcinoma cancer patients responding to crizotinib.
Onco Targets Ther
; 11: 7821-7825, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-30464529
17.
Concurrent ROS1 gene rearrangement and KRAS mutation in lung adenocarcinoma: A case report and literature review.
Thorac Cancer
; 9(1): 159-163, 2018 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28971587
18.
Hepatoid Adenocarcinoma of the Lung with EGFR Mutation and the Response to Tyrosine Kinase Inhibitors.
J Thorac Oncol
; 14(10): e217-e219, 2019 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-31558230